Volume | 0 |
|
|||||
Noticias | - |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Revelation Biosciences Inc | REVBW | NASDAQ | Warrant Capital Accionario |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
0.012 |
Operaciones | Volume Operado de la Acción | Volumen promedio |
---|---|---|
0 | 0 | - |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
- | 0 | 0.012 | USD |
Información Financiera Revelation Biosciences Inc REVBW
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
75.56k | 6.30M | - | 0 | -120k | -0.02 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Revelation Biosciences Inc REVBW
Fecha | Hora | Fuente | Noticia |
---|---|---|---|
08/11/2024 | 15:25 | Edgar (US Regulatory) | Form 8-K - Current report |
08/11/2024 | 15:00 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
21/10/2024 | 15:19 | Edgar (US Regulatory) | Form 8-K - Current report |
27/9/2024 | 15:09 | Edgar (US Regulatory) | Form 8-K - Current report |
23/9/2024 | 15:57 | Edgar (US Regulatory) | Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:.. |
23/9/2024 | 15:55 | Edgar (US Regulatory) | Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:.. |
23/9/2024 | 15:53 | Edgar (US Regulatory) | Form 10-K/A - Annual report [Section 13 and 15(d), not S-K.. |
13/9/2024 | 15:01 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
12/9/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
09/8/2024 | 15:24 | Edgar (US Regulatory) | Form 8-K - Current report |
09/8/2024 | 15:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
18/6/2024 | 16:08 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
Histórico REVBW
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |